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[2863.499] Evaluating the Duration of Post-Operative Cefuroxime Prophylaxis on 
Infectious Outcomes in Pediatric Cardiovascular Surgery Patients 
 
Chad A. Knoderer, Michelle D. Berg, Andrea H. Webster, Elaine G. Cox. Pharmacy Practice, 
Butler University College of Pharmacy and Health Sciences, Indianapolis, IN; Pediatrics, 
Ryan White Center for Pediatric Infectious Disease, Indiana University School of Medicine, 
Indianapolis, IN. 
 
BACKGROUND: Use of antimicrobials for prevention of surgical site infections after cardiac 
surgery is standard of care for adults and children, although practice variations exist in children 
with respect to optimal duration of prophylaxis. Despite recommendations to continue antibiotic 
prophylaxis for 24 to 72 hours after cardiac surgery, use of extended post-operative prophylaxis 
in children remains common. 
OBJECTIVE: To evaluate differences in infectious outcomes in children after cardiac surgery 
who received unlimited post-operative cefuroxime prophylaxis and those who received 
cefuroxime prophylaxis for a period of only 24 hours after surgery. 
DESIGN/METHODS: This was a retrospective study of children who had undergone cardiac 
surgery from February 2006 through January 2007. This time period represented six months 
prior to and after implementation of a change to a standard 24 hour duration of post-surgical 
cefuroxime prophylaxis. Patients in each time period (pre and post intervention) were 
categorized into two major infectious outcome groups based on whether or not they required 
additional treatment courses of antibiotics beyond cefuroxime prophylaxis. 
RESULTS: Two hundred and twelve children (103 pre-intervention and 109 post-intervention) 
met inclusion criteria. Additional antibiotics were initiated in 19 (18.4%) and 29 (26.6%) of 
patients in the pre and post-intervention groups, respectively (p = 0.156). Of these, documented 
bacterial infection (bacteremia, urinary tract infection, endocarditis, sepsis) occurred in 8 
(42.1%) and 14 (48.3%) in the pre and post-intervention groups, respectively (p = 0.675). As 
expected, prophylactic cefuroxime was continued for a greater mean duration in the pre-
intervention group (4.1 ± 3.3 vs. 1.2 ± 0.5 days, p < 0.005). 
CONCLUSIONS: Prolonged exposure to antibiotics contributes to development of antibiotic 
resistance in surrounding flora both immediately and upon later admissions. Since many cardiac 
procedures in children are staged over multiple admissions, the development of resistant 
organisms is a valid concern. Limiting the duration of cefuroxime prophylaxis to 24 hours after 
pediatric cardiac surgery does not appear to increase infectious outcomes or true post-operative 
infections. Our results underscore the need to develop standard prophylactic antibiotic regimens 
in institutions currently utilizing prolonged prophylaxis after pediatric cardiac surgery. 
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